Sonoma Biotherapeutics

Seattle, United States · Founded 2019 · $410.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$410.0M
Last Round
$75.0M Series ASep 2024
Rounds
7

About

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat autoimmune and inflammatory diseases by restoring balance to the immune system. Founded by pioneers in Treg biology and cell therapy, the company uses proprietary platform technologies to engineer targeted, durable Treg cell therapies. Its lead program targets rheumatoid arthritis, with additional indications in development through a collaboration with Regeneron.

Summary

Sonoma Biotherapeutics is a Biotech company based in Seattle, United States, founded in 2019. It has raised $410.0M in total across 7 rounds, most recently a $75.0M Series A round in Sep 2024. Investors include Regeneron Pharmaceuticals, GV and ARCH Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundRegeneron InvestmentSep 2024
$75.0M

Sign up to see all 7 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sonoma Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sonoma-biotherapeutics"><img src="https://indexed.vc/api/badge/company/sonoma-biotherapeutics" alt="Sonoma Biotherapeutics on Indexed.vc" width="260" height="76" /></a>